Exploring the Pharmacological Mechanism of Duhuo Jisheng Decoction in Treating Osteoporosis Based on Network Pharmacology

被引:22
|
作者
Xiong, Zhencheng [1 ,2 ]
Zheng, Can [3 ]
Chang, Yanan [4 ]
Liu, Kuankuan [4 ]
Shu, Li [4 ]
Zhang, Chi [1 ,3 ,4 ,5 ,6 ]
机构
[1] Peking Univ, Inst Med Technol, Hlth Sci Ctr, Beijing, Peoples R China
[2] Peking Univ Third Hosp, Beijing, Peoples R China
[3] Peking Univ, Biomed Engn Dept, Beijing, Peoples R China
[4] Peking Univ Int Hosp, Cent Lab, Beijing, Peoples R China
[5] Peking Univ Int Hosp, Dept Orthoped, Beijing, Peoples R China
[6] Beijing Univ Chinese Med, Sch Chinese Mat Med, Beijing, Peoples R China
关键词
OSTEOGENIC DIFFERENTIATION; STEM-CELLS; DATABASE;
D O I
10.1155/2021/5510290
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Objective. The purpose of this work is to study the mechanism of action of Duhuo Jisheng Decoction (DHJSD) in the treatment of osteoporosis based on the methods of bioinformatics and network pharmacology. Methods. In this study, the active compounds of each medicinal ingredient of DHJSD and their corresponding targets were obtained from TCMSP database. Osteoporosis was treated as search query in GeneCards, MalaCards, DisGeNET, Therapeutic Target Database (TTD), Comparative Toxicogenomics Database (CTD), and OMIM databases to obtain disease-related genes. The overlapping targets of DHJSD and osteoporosis were identified, and then GO and KEGG enrichment analysis were performed. Cytoscape was employed to construct DHJSD-compounds-target genes-osteoporosis network and protein-protein interaction (PPI) network. CytoHubba was utilized to select the hub genes. The activities of binding of hub genes and key components were confirmed by molecular docking. Results. 174 active compounds and their 205 related potential targets were identified in DHJSD for the treatment of osteoporosis, including 10 hub genes (AKT1, ALB, IL6, MAPK3, VEGFA, JUN, CASP3, EGFR, MYC, and EGF). Pathway enrichment analysis of target proteins indicated that osteoclast differentiation, AGE-RAGE signaling pathway in diabetic complications, Wnt signaling pathway, MAPK signaling pathway, PI3K-Akt signaling pathway, JAK-STAT signaling pathway, calcium signaling pathway, and TNF signaling pathway were the specifically major pathways regulated by DHJSD against osteoporosis. Further verification based on molecular docking results showed that the small molecule compounds (Quercetin, Kaempferol, Beta-sitosterol, Beta-carotene, and Formononetin) contained in DHJSD generally have excellent binding affinity to the macromolecular target proteins encoded by the top 10 genes. Conclusion. This study reveals the characteristics of multi-component, multi-target, and multi-pathway of DHJSD against osteoporosis and provides novel insights for verifying the mechanism of DHJSD in the treatment of osteoporosis.
引用
收藏
页数:21
相关论文
共 50 条
  • [21] Study on the Mechanism of Huanglian Jiedu Decoction in Treating Dyslipidemia Based on Network Pharmacology
    Gong, Zhaohui
    Li, Rong
    Chen, Shulin
    Wu, Hui
    Cai, Yinhe
    Li, Junlong
    Zhao, Xinjun
    Chu, Qingmin
    Luo, Chuanjin
    Qing, Lijin
    Li, Nan
    Wu, Wei
    Journal of Healthcare Engineering, 2022, 2022
  • [22] RETRACTED: Efficacy of Duhuo Jisheng Decoction in Treating Ankylosing Spondylitis: Clinical Evidence and Potential Mechanisms (Retracted Article)
    Wang, Yi
    Zhou, Zhihua
    Chen, Li
    He, Xiangwei
    Li, Hui
    Huang, Yingru
    Pu, Yu
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022
  • [23] Study on the Mechanism of Huanglian Jiedu Decoction in Treating Dyslipidemia Based on Network Pharmacology
    Gong, Zhaohui
    Li, Rong
    Chen, Shulin
    Wu, Hui
    Cai, Yinhe
    Li, Junlong
    Zhao, Xinjun
    Chu, Qingmin
    Luo, Chuanjin
    Qing, Lijin
    Li, Nan
    Wu, Wei
    JOURNAL OF HEALTHCARE ENGINEERING, 2022, 2022
  • [24] Mechanism of Liuwei Dihuang Pills in treating osteoporosis based on network pharmacology
    Wang, Xiqoqiang
    Li, Hongtao
    Long, Longhai
    Song, Chao
    Chen, Rui
    Pan, Hongyu
    Qiu, Junjie
    Liu, Bing
    Liu, Zongchao
    MEDICINE, 2023, 102 (42) : E34773
  • [25] Mechanism investigation of Duhuo Jisheng pill against rheumatoid arthritis based on a strategy for the integration of network pharmacology, molecular docking and in vivo experimental verification
    Xin, Ping
    Xu, Xiaoyun
    Zhang, Huaxi
    Hu, Yuezhou
    Deng, Chengjie
    Sun, Shiqin
    Liu, Shuang
    Zhou, Xuegang
    Ma, Hongxing
    Li, Xiaoliang
    PHARMACEUTICAL BIOLOGY, 2023, 61 (01) : 1431 - 1445
  • [26] Exploring the pharmacological mechanism of Xianlingubao against diabetic osteoporosis based on network pharmacology and molecular docking: An observational study
    Yan, Huili
    Li, Zongying
    Zhang, Zhongwen
    MEDICINE, 2024, 103 (31)
  • [27] Exploring the Mechanism of Yi-Jing Decoction in Treating Polycystic Ovary Syndrome by Using Network Pharmacology
    Lin, Yue
    Xiang, Liu
    Li, Xianhai
    Tang, Qiang
    Meng, Fanbo
    Chen, Wei
    CURRENT MEDICINAL CHEMISTRY, 2023, 30 (21) : 2463 - 2474
  • [28] Study on the mechanism of Baihe Dihuang decoction in treating menopausal syndrome based on network pharmacology
    Tian, Mingmin
    Yang, Anming
    Lu, Qinwei
    Zhang, Xin
    Liu, Guangjie
    Liu, Gaofeng
    MEDICINE, 2023, 102 (20) : E33189
  • [29] Mechanism of Wulan Shisanwei Decoction in Treating Hypertension Complicated with Hyperlipidemia Based on Network Pharmacology
    Aruohan BAO
    Burenbatu
    Medicinal Plant, 2023, (01) : 64 - 68
  • [30] Studies on the Mechanism of Gegen Qinlian Decoction in Treating Diabetes Mellitus Based on Network Pharmacology
    Deng, Xiaodong
    Liang, Yuhua
    Hu, Jianmei
    Yang, Yuhui
    NATURAL PRODUCT COMMUNICATIONS, 2021, 16 (01)